High-dose sequential therapy and single autologous transplantation for multiple myeloma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions
- 12 Dec 2017 Biomarkers information updated
- 08 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2009 Planned end date (1 Apr 2010) added as reported by ClinicalTrials.gov.